Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease
Marc Aurel Busche,1,4
Gerhard Eichhoff,1,4
Helmuth Adelsberger,1,4
Dorothee Abramowski,2
Karl-Heinz Wiederhold,2
Christian Haass,3,4
Matthias Staufenbiel,2
Arthur Konnerth,1,4*
Olga Garaschuk1,4
Abstract:
The neurodegeneration observed in Alzheimer's disease has beenassociated with synaptic dismantling and progressive decreasein neuronal activity. We tested this hypothesis in vivo by usingtwo-photon Ca2+ imaging in a mouse model of Alzheimer's disease.Although a decrease in neuronal activity was seen in 29% oflayer 2/3 cortical neurons, 21% of neurons displayed an unexpectedincrease in the frequency of spontaneous Ca2+ transients. These"hyperactive" neurons were found exclusively near the plaquesof amyloid β–depositing mice. The hyperactivity appearedto be due to a relative decrease in synaptic inhibition. Thus,we suggest that a redistribution of synaptic drive between silentand hyperactive neurons, rather than an overall decrease insynaptic activity, provides a mechanism for the disturbed corticalfunction in Alzheimer's disease.
1 Institut für Neurowissenschaften, Technische Universität München (TUM), 80802 München, Germany. 2 Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland. 3 Adolf-Butenandt-Institute, Department of Biochemistry, Laboratory for Neurodegenerative Disease Research, Ludwig-Maximilians-Universität, 80336 München, Germany. 4 Center for Integrated Protein Science, 81377 München, Germany.
Present address: Institute of Physiology II, Wilhelmstraße27, 72074 Tübingen, Germany.
* To whom correspondence should be addressed. E-mail: arthur.konnerth{at}lrz.tum.de
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Stella M. Hurtley (23 September 2008) Sci. Signal.1 (38), ec331.
[DOI: 10.1126/scisignal.138ec331] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Novel Nicotinic Mechanism Underlies {beta}-Amyloid-Induced Neuronal Hyperexcitation.
Q. Liu, X. Xie, R. J. Lukas, P. A. St. John, and J. Wu (2013)
J. Neurosci.
33, 7253-7263
|Abstract »|Full Text »|PDF »
Sodium Channel Cleavage Is Associated with Aberrant Neuronal Activity and Cognitive Deficits in a Mouse Model of Alzheimer's Disease.
B. F. Corbett, S. C. Leiser, H.-P. Ling, R. Nagy, N. Breysse, X. Zhang, A. Hazra, A. Wood, M. N. Pangalos, P. H. Reinhart, et al. (2013)
J. Neurosci.
33, 7020-7026
|Abstract »|Full Text »|PDF »
Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of {beta}-Amyloid in Mice with Alzheimer's Disease Pathology.
J. H. Roh, Y. Huang, A. W. Bero, T. Kasten, F. R. Stewart, R. J. Bateman, and D. M. Holtzman (2012)
Science Translational Medicine
4, 150ra122
|Abstract »|Full Text »|PDF »
Interaction between Amyloid-{beta} Pathology and Cortical Functional Columnar Organization.
S. Beker, V. Kellner, L. Kerti, and E. A. Stern (2012)
J. Neurosci.
32, 11241-11249
|Abstract »|Full Text »|PDF »
In Vivo Alterations in Calcium Buffering Capacity in Transgenic Mouse Model of Synucleinopathy.
L. Reznichenko, Q. Cheng, K. Nizar, S. L. Gratiy, P. A. Saisan, E. M. Rockenstein, T. Gonzalez, C. Patrick, B. Spencer, P. Desplats, et al. (2012)
J. Neurosci.
32, 9992-9998
|Abstract »|Full Text »|PDF »
Neurotoxicity of Amyloid {beta}-Protein: Synaptic and Network Dysfunction.
Critical role of soluble amyloid-{beta} for early hippocampal hyperactivity in a mouse model of Alzheimer's disease.
M. A. Busche, X. Chen, H. A. Henning, J. Reichwald, M. Staufenbiel, B. Sakmann, and A. Konnerth (2012)
PNAS
109, 8740-8745
|Abstract »|Full Text »|PDF »
Synapses and Alzheimer's Disease.
M. Sheng, B. L. Sabatini, and T. C. Sudhof (2012)
Cold Spring Harb Perspect Biol
4, a005777
|Abstract »|Full Text »|PDF »
Brain Imaging in Alzheimer Disease.
K. A. Johnson, N. C. Fox, R. A. Sperling, and W. E. Klunk (2012)
Cold Spring Harb Perspect Med
2, a006213
|Abstract »|Full Text »|PDF »
Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology.
M. Higuchi, N. Iwata, Y. Matsuba, J. Takano, T. Suemoto, J. Maeda, B. Ji, M. Ono, M. Staufenbiel, T. Suhara, et al. (2012)
FASEB J
26, 1204-1217
|Abstract »|Full Text »|PDF »
Inhibition of the NFAT Pathway Alleviates Amyloid Beta Neurotoxicity in a Mouse Model of Alzheimer's Disease.
E. Hudry, H.-Y. Wu, M. Arbel-Ornath, T. Hashimoto, R. Matsouaka, Z. Fan, T. L. Spires-Jones, R. A. Betensky, B. J. Bacskai, and B. T. Hyman (2012)
J. Neurosci.
32, 3176-3192
|Abstract »|Full Text »|PDF »
A{beta} neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors.
H. You, S. Tsutsui, S. Hameed, T. J. Kannanayakal, L. Chen, P. Xia, J. D. T. Engbers, S. A. Lipton, P. K. Stys, and G. W. Zamponi (2012)
PNAS
109, 1737-1742
|Abstract »|Full Text »|PDF »
Hippocampal Hyperactivation Associated with Cortical Thinning in Alzheimer's Disease Signature Regions in Non-Demented Elderly Adults.
D. Putcha, M. Brickhouse, K. O'Keefe, C. Sullivan, D. Rentz, G. Marshall, B. Dickerson, and R. Sperling (2011)
J. Neurosci.
31, 17680-17688
|Abstract »|Full Text »|PDF »
Sensory Network Dysfunction, Behavioral Impairments, and Their Reversibility in an Alzheimer's {beta}-Amyloidosis Mouse Model.
D. W. Wesson, A. H. Borkowski, G. E. Landreth, R. A. Nixon, E. Levy, and D. A. Wilson (2011)
J. Neurosci.
31, 15962-15971
|Abstract »|Full Text »|PDF »
Two-Photon Imaging of Neural Networks in a Mouse Model of Alzheimer's Disease.
G. Eichhoff and O. Garaschuk (2011)
Cold Spring Harb Protoc
2011, pdb.prot065789
|Abstract »|Full Text »|PDF »
Amyloid {beta} Peptide-(1-42) Induces Internalization and Degradation of {beta}2 Adrenergic Receptors in Prefrontal Cortical Neurons.
D. Wang, E. Y. Yuen, Y. Zhou, Z. Yan, and Y. K. Xiang (2011)
J. Biol. Chem.
286, 31852-31863
|Abstract »|Full Text »|PDF »
Attenuated A{beta}42 Responses to Low Potency {gamma}-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds.
B. Kretner, A. Fukumori, A. Gutsmiedl, R. M. Page, T. Luebbers, G. Galley, K. Baumann, C. Haass, and H. Steiner (2011)
J. Biol. Chem.
286, 15240-15251
|Abstract »|Full Text »|PDF »
Alzheimer's Disease: The Challenge of the Second Century.
D. M. Holtzman, J. C. Morris, and A. M. Goate (2011)
Science Translational Medicine
3, 77sr1
|Full Text »|PDF »
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease.
J. Mulder, M. Zilberter, S. J. Pasquare, A. Alpar, G. Schulte, S. G. Ferreira, A. Kofalvi, A. M. Martin-Moreno, E. Keimpema, H. Tanila, et al. (2011)
Brain
134, 1041-1060
|Abstract »|Full Text »|PDF »
Robust Amyloid Clearance in a Mouse Model of Alzheimer's Disease Provides Novel Insights into the Mechanism of Amyloid-{beta} Immunotherapy.
A. Wang, P. Das, R. C. Switzer III, T. E. Golde, and J. L. Jankowsky (2011)
J. Neurosci.
31, 4124-4136
|Abstract »|Full Text »|PDF »
Noninvasive Magnetic Resonance Imaging Detection of Cerebral Amyloid Angiopathy-Related Microvascular Alterations Using Superparamagnetic Iron Oxide Particles in APP Transgenic Mouse Models of Alzheimer's Disease: Application to Passive A{beta} Immunotherapy.
N. Beckmann, C. Gerard, D. Abramowski, C. Cannet, and M. Staufenbiel (2011)
J. Neurosci.
31, 1023-1031
|Abstract »|Full Text »|PDF »
Amyloid-{beta}/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease.
E. D. Roberson, B. Halabisky, J. W. Yoo, J. Yao, J. Chin, F. Yan, T. Wu, P. Hamto, N. Devidze, G.-Q. Yu, et al. (2011)
J. Neurosci.
31, 700-711
|Abstract »|Full Text »|PDF »
Calpain Activation Promotes BACE1 Expression, Amyloid Precursor Protein Processing, and Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease.
B. Liang, B.-Y. Duan, X.-P. Zhou, J.-X. Gong, and Z.-G. Luo (2010)
J. Biol. Chem.
285, 27737-27744
|Abstract »|Full Text »|PDF »
Binding of amyloid {beta} peptide to {beta}2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity.
D. Wang, G. Govindaiah, R. Liu, V. De Arcangelis, C. L. Cox, and Y. K. Xiang (2010)
FASEB J
24, 3511-3521
|Abstract »|Full Text »|PDF »
Decreased Rhythmic GABAergic Septal Activity and Memory-Associated {theta} Oscillations after Hippocampal Amyloid-{beta} Pathology in the Rat.
V. Villette, F. Poindessous-Jazat, A. Simon, C. Lena, E. Roullot, B. Bellessort, J. Epelbaum, P. Dutar, and A. Stephan (2010)
J. Neurosci.
30, 10991-11003
|Abstract »|Full Text »|PDF »
{beta}-Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1.
J. Espana, J. Valero, A. J. Minano-Molina, R. Masgrau, E. Martin, C. Guardia-Laguarta, A. Lleo, L. Gimenez-Llort, J. Rodriguez-Alvarez, and C. A. Saura (2010)
J. Neurosci.
30, 9402-9410
|Abstract »|Full Text »|PDF »
Role of Presenilins in Neuronal Calcium Homeostasis.
H. Zhang, S. Sun, A. Herreman, B. De Strooper, and I. Bezprozvanny (2010)
J. Neurosci.
30, 8566-8580
|Abstract »|Full Text »|PDF »
Calcium Signaling and Amyloid Toxicity in Alzheimer Disease.
A. Demuro, I. Parker, and G. E. Stutzmann (2010)
J. Biol. Chem.
285, 12463-12468
|Abstract »|Full Text »|PDF »
Amyloid {beta} Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation.
H.-Y. Wu, E. Hudry, T. Hashimoto, K. Kuchibhotla, A. Rozkalne, Z. Fan, T. Spires-Jones, H. Xie, M. Arbel-Ornath, C. L. Grosskreutz, et al. (2010)
J. Neurosci.
30, 2636-2649
|Abstract »|Full Text »|PDF »
A Reporter of Local Dendritic Translocation Shows Plaque- Related Loss of Neural System Function in APP-Transgenic Mice.
M. Meyer-Luehmann, M. Mielke, T. L. Spires-Jones, W. Stoothoff, P. Jones, B. J. Bacskai, and B. T. Hyman (2009)
J. Neurosci.
29, 12636-12640
|Abstract »|Full Text »|PDF »
Sparsification of neuronal activity in the visual cortex at eye-opening.
N. L. Rochefort, O. Garaschuk, R.-I. Milos, M. Narushima, N. Marandi, B. Pichler, Y. Kovalchuk, and A. Konnerth (2009)
PNAS
106, 15049-15054
|Abstract »|Full Text »|PDF »
Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice.
P. Yan, A. W. Bero, J. R. Cirrito, Q. Xiao, X. Hu, Y. Wang, E. Gonzales, D. M. Holtzman, and J.-M. Lee (2009)
J. Neurosci.
29, 10706-10714
|Abstract »|Full Text »|PDF »
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease.
M. I. Fonseca, R. R. Ager, S.-H. Chu, O. Yazan, S. D. Sanderson, F. M. LaFerla, S. M. Taylor, T. M. Woodruff, and A. J. Tenner (2009)
J. Immunol.
183, 1375-1383
|Abstract »|Full Text »|PDF »
R. Minkeviciene, S. Rheims, M. B. Dobszay, M. Zilberter, J. Hartikainen, L. Fulop, B. Penke, Y. Zilberter, T. Harkany, A. Pitkanen, et al. (2009)
J. Neurosci.
29, 3453-3462
|Abstract »|Full Text »|PDF »
Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice.
K. V. Kuchibhotla, C. R. Lattarulo, B. T. Hyman, and B. J. Bacskai (2009)
Science
323, 1211-1215
|Abstract »|Full Text »|PDF »